Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and in Vivo Antifungal Managements of Vulvovaginal Candidiasis

Cellular Physiology and Biochemistry

Volumn 40, Issue 3-4, 2016, Pages 727-742

  Gao, Mei ^a   Wang, Hui ^a   Zhu, Lijuan ^a  

^a FIRST PEOPLE S HOSPITAL OF SHANGQIU   (China)

Author keywords

Biofilm; Candida albicans; Fluconazole; Quercetin; Vulvovaginal candidiasis

Indexed keywords

FLUCONAZOLE; QUERCETIN; ANTIFUNGAL AGENT; MESSENGER RNA;

ALS1 GENE; ALS3 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOFILM ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DISPERSION; DOWN REGULATION; DRUG POTENTIATION; ECE1 GENE; FEMALE; FLOCCULATION; FUNGAL CELL; FUNGAL METABOLISM; GENE; GENE EXPRESSION; HSP90 GENE; HWP1 GENE; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; NRG1 GENE; PDE2 GENE; PRIORITY JOURNAL; SUN41 GENE; UME6 GENE; UPREGULATION; VAGINA CANDIDIASIS; VAGINA MUCOSA; ANIMAL; BACTERIUM ADHERENCE; BIOFILM; CANDIDIASIS, VULVOVAGINAL; CELL MEMBRANE; CHEMICAL PHENOMENA; DISEASE MODEL; DRUG EFFECTS; FUNGUS HYPHAE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGY; PLANKTON;

ANIMALS; ANTIFUNGAL AGENTS; BACTERIAL ADHESION; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CELL MEMBRANE; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; FEMALE; FLOCCULATION; FLUCONAZOLE; GENE EXPRESSION REGULATION, FUNGAL; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPHAE; MICE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PLANKTON; QUERCETIN; RNA, MESSENGER;

EID: 85001020550     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000453134     Document Type: Article

References (60)

1. Foxman B, Marsh JV, Gillespie B, Sobel JD: Frequency and response to vaginal symptoms among white and african American women: Results of a random digit dialing survey. J Womens Health 1998;7:1167-1174.
2. Sobel JD: Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2016;214:15-21.
3. Fidel PL, Jr., Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, Quayle AJ, Dunlap K: An intravaginal live candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 2004;72:2939-2946.
4. Fidel PL, Jr.: History and update on host defense against vaginal candidiasis. Am J Reprod Immunol 2007;57:2-12.
5. Fan S, Liao Q, Liu X, Liu Z, Zhang D: Vaginal allergic response in women with vulvovaginal candidiasis. Int J Gynecol Obstet 2008;101:27-30.
6. Achkar JM, Fries BC: Candida infections of the genitourinary tract. Clin Microbiol Rev 2010;23:253-273.
7. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA: Antifungal susceptibilities of candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 2005;43:2155-2162.
8. Choukri F, Benderdouche M, Sednaoui P: In vitro susceptibility profile of 200 recent clinical isolates of candida spp. To topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. J Mycol Med 2014;24:303-307.
9. Sobel JD: Vulvovaginal candidosis. Lancet 2007;369:1961-1971.
10. Al-Fattani MA, Douglas LJ: Biofilm matrix of candida albicans and candida tropicalis: Chemical composition and role in drug resistance. J Med Microbiol 2006;55:999-1008.
11. Tobudic S, Kratzer C, Lassnigg A, Presterl E: Antifungal susceptibility of candida albicans in biofilms. Mycoses 2012;55:199-204.
12. Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, Kohler JR, Kadosh D, Lopez-Ribot JL: Dispersion as an important step in the candida albicans biofilm developmental cycle. PLoS Pathog 2010;6:e1000828.
13. Taff HT, Mitchell KF, Edward JA, Andes DR: Mechanisms of candida biofilm drug resistance. Future Microbiol 2013;8:1325-1337.
14. Zavrel M, White TC: Medically important fungi respond to azole drugs: An update. Future Microbiol 2015;10:1355-1373.
15. Costa M, Passos XS, Miranda AT, de Araujo RS, Paula CR, Silva Mdo R: Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis. Mycopathologia 2004;157:43-47.
16. Ying C, Zhang H, Tang Z, Chen H, Gao J, Yue C: Antifungal susceptibility and molecular typing of 115 candida albicans isolates obtained from vulvovaginal candidiasis patients in 3 shanghai maternity hospitals. Med Mycol 2016;54:394-399.
17. Shi XY, Yang YP, Zhang Y, Li W, Wang JD, Huang WM, Fan YM: Molecular identification and antifungal susceptibility of 186 candida isolates from vulvovaginal candidiasis in southern China. J Med Microbiol 2015;64:390-393.
18. Singh BN, Upreti DK, Singh BR, Pandey G, Verma S, Roy S, Naqvi AH, Rawat AK: Quercetin sensitizes fluconazole-resistant candida albicans to induce apoptotic cell death by modulating quorum sensing. Antimicrob Agents Chemother 2015;59:2153-2168.
19. Shahzad M, Sherry L, Rajendran R, Edwards CA, Combet E, Ramage G: Utilising polyphenols for the clinical management of candida albicans biofilms. Int J Antimicrob Agents 2014;44:269-273.
20. CLSI: Clinical and laboratory standards institute reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard document M27-A3, ed 3, revised, Wayne, pennsylvania, USA, 2008, vol 28, pp 3-16.
21. Odds F: Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003;52:1.
22. Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ: In vitro interactions between farnesol and fluconazole, amphotericin b or micafungin against candida albicans biofilms. J Antimicrob Chemother 2015;70:470-478.
23. Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Jr., Mowat E, Ramage G, Lopez-Ribot JL: A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 2008;3:1494-1500.
24. Khodavandi A, Alizadeh F, Vanda NA, Karimi G, Chong PP: Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against candida albicans. Pharm Biol 2014;52:1505-1509.
25. Eliopoulos GM, Eliopoulos CT: Antibiotic combinations: Should they be tested Clin Microbiol Rev 1988;1:139-156.
26. Cao YY, Cao YB, Xu Z, Ying K, Li Y, Xie Y, Zhu ZY, Chen WS, Jiang YY: Cdna microarray analysis of differential gene expression in candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 2005;49:584-589.
27. Gelis S, de Groot PW, Castillo L, Moragues MD, Sentandreu R, Gomez MM, Valentin E: Pga13 in candida albicans is localized in the cell wall and influences cell surface properties, morphogenesis and virulence. Fungal Genet Biol 2012;49:322-331.
28. Sun L, Liao K, Wang D: Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by candida albicans. PLoS One 2015;10:e0117695.
29. Shao J, Zhang M, Wang T, Li Y, Wang C: The roles of cdr1, cdr2, and mdr1 in kaempferol-induced suppression with fluconazole-resistant candida albicans. Pharm Biol 2016;54:984-992.
30. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative pcr and the 2 ct method. Methods 2001;25:402-408.
31. Yano J, Fidel PL, Jr.: Protocols for vaginal inoculation and sample collection in the experimental mouse model of candida vaginitis. J Vis Exp 2011;58:e3382.
32. Kittl M, Beyreis M, Tumurkhuu M, Fürst J, Helm K, Pitschmann A, Gaisberger M, Glasl S, Ritter M, Jakab M: Quercetin stimulates insulin secretion and reduces the viability of rat INS-1 beta-cells. Cell Physiol Biochem 2016;39:278-293.
33. Gim H, Nam JH, Lee S, Shim JH, Kim HJ, Ha KT, Kim BJ: Quercetin inhibits pacemaker potentials via nitric oxide/cGMP-dependent activation and RPM7/ANO1 channels in cultured interstitial cells of cajal from mouse small intestine. Cell Physiol Biochem 2015;35:2422-2436.
34. Lou G, Liu Y, Wu S, Xue J, Yang F, Fu H, Zheng M, Chen Z: The p53/MIR-34a/SIRT1 positive feedback loop in quercetin-induced apoptosis. Cell Physiol Biochem 2015;35:2192-2202.
35. Hirasawa M, Takada K: Multiple effects of green tea catechin on the antifungal activity of antimycotics against candida albicans. J Antimicrob Chemother 2004;53:225-229.
36. Wang TM, Shi G, Shao J, Wu D, Yan Y, Zhang M, Cui Y, Wang C: In vitro antifungal activity of baicalin against candida albicans biofilms via apoptotic induction. Microb Pathog 2015;87:21-29.
37. De Cremer K, Staes I, Delattin N, Cammue BP, Thevissen K, De Brucker K: Combinatorial drug approaches to tackle candida albicans biofilms. Expert Rev Anti Infect Ther 2015;13:973-984.
38. Uppuluri P, Chaturvedi AK, Lopez-Ribot JL: Design of a simple model of candida albicans biofilms formed under conditions of flow: Development, architecture, and drug resistance. Mycopathologia 2009;168:101-109.
39. Shao J, Lu KQ, Tian G, Cui YY, Yan YY, Wang TM, Zhang XL, Wang CZ: Lab-scale preparations of candida albicans and dual candida albicans-candida glabrata biofilms on the surface of medical-grade polyvinyl chloride (pvc) perfusion tube using a modified gravity-supported free-flow biofilm incubator (gs-ffbi). J Microbiol Methods 2015;109:41-48.
40. Paiva LC, Vidigal PG, Donatti L, Svidzinski TI, Consolaro ME: Assessment of in vitro biofilm formation by candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics. Micron 2012;43:497-502.
41. Chassot F, Negri MF, Svidzinski AE, Donatti L, Peralta RM, Svidzinski TI, Consolaro ME: Can intrauterine contraceptive devices be a candida albicans reservoir Contraception 2008;77:355-359.
42. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, Edwards JE, Filler SG, Mitchell AP: Critical role of bcr1-dependent adhesins in c. Albicans biofilm formation in vitro and in vivo. PLoS Pathog 2006;2:e63.
43. Yeater KM, Chandra J, Cheng G, Mukherjee PK, Zhao X, Rodriguez-Zas SL, Kwast KE, Ghannoum MA, Hoyer LL: Temporal analysis of candida albicans gene expression during biofilm development. Microbiology 2007;153:2373-2385.
44. Green CB, Zhao X, Yeater KM, Hoyer LL: Construction and real-time rt-pcr validation of candida albicans pals-gfp reporter strains and their use in flow cytometry analysis of als gene expression in budding and filamenting cells. Microbiology 2005;151:1051-1060.
45. Sundstrom P: Adhesion in candida spp. Cell Microbiol 2002;4:461-469.
46. Nobile CJ, Nett JE, Andes DR, Mitchell AP: Function of candida albicans adhesin hwp1 in biofilm formation. Eukaryot Cell 2006;5:1604-1610.
47. Kolecka A, Chorvat D, Jr., Bujdakova H: The impact of growth conditions on biofilm formation and the cell surface hydrophobicity in fluconazole susceptible and tolerant candida albicans. Folia Microbiol (Praha) 2015;60:45-51.
48. Silva-Dias A, Miranda IM, Branco J, Monteiro-Soares M, Pina-Vaz C, Rodrigues AG: Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: Relationship among candida spp. Front Microbiol 2015;6:205.
49. Verstrepen KJ, Klis FM: Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol 2006;60:5-15.
50. Sudbery PE: Growth of candida albicans hyphae. Nat Rev Microbiol 2011;9:737-748.
51. Argimon S, Wishart JA, Leng R, Macaskill S, Mavor A, Alexandris T, Nicholls S, Knight AW, Enjalbert B, Walmsley R, Odds FC, Gow NA, Brown AJ: Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen candida albicans. Eukaryot Cell 2007;6:682-692.
52. Hoyer LL, Payne TL, Bell M, Myers AM, Scherer S: Candida albicans als3 and insights into the nature of the als gene family. Curr Genet 1998;33:451-459.
53. Nailis H, Vandenbroucke R, Tilleman K, Deforce D, Nelis H, Coenye T: Monitoring als1 and als3 gene expression during in vitro candida albicans biofilm formation under continuous flow conditions. Mycopathologia 2009;167:9-17.
54. Norice CT, Smith FJ, Jr., Solis N, Filler SG, Mitchell AP: Requirement for candida albicans sun41 in biofilm formation and virulence. Eukaryot Cell 2007;6:2046-2055.
55. Banerjee M, Uppuluri P, Zhao XR, Carlisle PL, Vipulanandan G, Villar CC, Lopez-Ribot JL, Kadosh D: Expression of ume6, a key regulator of candida albicans hyphal development, enhances biofilm formation via hgc1-and sun41-dependent mechanisms. Eukaryot Cell 2013;12:224-232.
56. Fan Y, He H, Dong Y, Pan H: Hyphae-specific genes hgc1, als3, hwp1, and ece1 and relevant signaling pathways in candida albicans. Mycopathologia 2013;176:329-335.
57. Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL: The transcriptional regulator nrg1p controls candida albicans biofilm formation and dispersion. Eukaryot Cell 2010;9:1531-1537.
58. Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE: Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog 2011;7:e1002257.
59. Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Jr., Noverr MC: Candida albicans forms biofilms on the vaginal mucosa. Microbiology 2010;156:3635-3644.
60. Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL, Jr., Noverr MC: Fungal morphogenetic pathways are required for the hallmark inflammatory response during candida albicans vaginitis. Infect Immun 2014;82:532-543.